A detailed history of Carr Financial Group Corp transactions in Novartis Ag stock. As of the latest transaction made, Carr Financial Group Corp holds 5,280 shares of NVS stock, worth $553,713. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,280
Previous 5,280 -0.0%
Holding current value
$553,713
Previous $562 Million 8.04%
% of portfolio
0.18%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$92.57 - $107.37 $2,499 - $2,898
27 Added 0.51%
5,280 $562 Million
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $396,864 - $486,007
5,253 New
5,253 $477 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $226B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Carr Financial Group Corp Portfolio

Follow Carr Financial Group Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carr Financial Group Corp, based on Form 13F filings with the SEC.

News

Stay updated on Carr Financial Group Corp with notifications on news.